Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The B-cell receptor (BCR) repertoire specific for vaccine antigens is the collection of unique antigen-binding receptors expressed by B cells that have been activated or selected by a vaccine (Nielsen et al., 2018, Nature Reviews Rheumatology). Each BCR consists of two identical heavy chains and two identical light chains, forming a complex that recognizes specific epitopes on the vaccine's immunogen (Janeway et al., 2001, Immunobiology). Upon binding, the BCR initiates intracellular signaling pathways that lead to B-cell proliferation, isotype switching, and somatic hypermutation within germinal centers (Victora & Nussenzweig, 2012, Annual Review of Immunology). This process results in the expansion of high-affinity clones that provide long-term immunity through the production of neutralizing antibodies and the establishment of memory B-cell populations (Galson et al., 2014, Frontiers in Immunology). Analyzing the diversity and evolution of this repertoire is a key component of modern vaccinology, used to evaluate the breadth of protection and to guide the development of next-generation vaccines (Phad et al., 2020, Trends in Immunology). While the repertoire itself is a biological readout rather than a single druggable molecule, it is the fundamental basis for the efficacy of all B-cell-mediated vaccines (Wen et al., 2022, Nature Communications).
Vaccines act as exogenous antigens that bind to and cross-link specific B-cell receptors, initiating clonal expansion, somatic hypermutation, and affinity maturation to generate a protective antibody response (Janeway et al., 2001, Immunobiology).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B-cell receptor repertoire (BCR repertoire).